 |
|
Information provided will be used by the medical community and confidentiality of the information is restricted to the ICDO Board of Directors. It is intended to be used for medical evaluations and research so that commonalities may be to find a cure for this rare disease.
|
Chugai Pharmaceuticals
2-1-1,Nihonbashi-
Muromachi
Chuo-ku,Tokyo, Japan 104-8301

Hoffmann-La Roche Pharmaceuticals-U.S.
Hoffmann-LaRoche Inc.
(Headquarters of Roche No. American
Pharmaceuticals Operations)
340 Kingsland Street
Nutley, NJ 07110

SPONSORS
Chugai Pharmaceuticals
Tokyo, JP
Cleveland Clinic
Cleveland, OH
Dana Farber
Cancer Institute
Boston, MA
H. Lee Moffitt
Cancer Center
& Research Institute
Tampa, FL
Hoffmann-LaRoche Pharmaceuticals
Nutley, NJ
Mayo Clinic
Rochester, MN
McDermott Will
& Emery
Los Angeles, CA
Osaka University
Osaka, JP
University of Arkansas for
Medical Science
Little Rock, AR
University
of Washington
Fred Hutchinson
Seattle, WA
Celgene Pharmaceuticals
Summit, NJ
|
DISCLAIMER:
CASTLEMAN's DISEASE HOMEPAGE is provided for educational purposes only. Consult your own physician regarding the applicability of any opinions or recommendations with respect to your symptoms or medical condition.
* CASTLEMAN's DISEASE HOMEPAGE is intended as a reference for health care professionals. The authors and editors have used sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.
Medical knowledge changes rapidly. In view of the possibility of human error or changes in medical science, neither the authors, the editors, St. Vincent Hospital, nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information. Readers are encouraged to confirm the information contained herein with other sources.
|
|